SMITH MARK ALAN (CHIEF MEDICAL OFFICER) received a stock award from VISTAGEN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/1/2020ACC: 0001415889-20-001766
Officer· CHIEF MEDICAL OFFICER
Since Aug 2018
+5K
Net shares
Net buyer
$2.2K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$0.45
Trade value
$2.24K
% of position
New position
6/30/2020
0.00→5K
Total
Net shares
+5K
Net value
$2.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2020 | A · Award | +5K | $0.45 | $2.24K | New position | 0.00 | 5K |
| Total | +5K | $2.24K | ||||||
Derivative Transactions0
No derivative transactions reported